Actinogen Medical Limited (ATGGF)
OTCMKTS
· Delayed Price · Currency is USD
0.0150
-0.0050 (-25.00%)
Jun 25, 2025, 8:00 PM EDT
Actinogen Medical Revenue
Actinogen Medical had revenue of 9.02M AUD in the twelve months ending December 31, 2024, up 88.25% year-over-year. In the fiscal year ending June 30, 2024, Actinogen Medical had annual revenue of 9.93M with 103.18% growth.
Revenue (ttm)
9.02M AUD
Revenue Growth
+88.25%
P/S Ratio
8.46
Revenue / Employee
930.59K AUD
Employees
n/a
Market Cap
47.23M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 9.93M | 5.04M | 103.18% |
| Jun 30, 2023 | 4.89M | 1.25M | 34.28% |
| Jun 30, 2022 | 3.64M | 1.66M | 83.47% |
| Jun 30, 2021 | 1.98M | -1.53M | -43.58% |
| Jun 30, 2020 | 3.52M | -1.35M | -27.69% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Actinogen Medical News
- 2 months ago - Actinogen provides pivotal Alzheimer's trial enrolment update and other business news - Benzinga